Nick Verougstraete

7PUBLICATIONS
46CO-AUTHORS
PharmacogenomicsBiologically active moleculesMetabolomic chemistryLife cycle assessment and industrial ecologyMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 15, 2026
Risk factors for suboptimal target attainment of commonly used ß-lactam antibiotics in older adults: a prospective cohort study.

Arnaud De Clercq, Tania Desmet, Jerina Boelens

|Sep 25, 2025
Fast and reliable in vitro activity-based detection of synthetic cannabinoid receptor agonists in e-liquids.

Axelle Timmerman, Cathelijne Lyphout, Nick Verougstraete

|Oct 01, 2022
Identification of etazene (etodesnitazene) metabolites in human urine by LC-HRMS.

Nick Verougstraete, Annick Verhaeghe, Jan Germonpré

|Oct 10, 2020
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity.

Suzanne J F Kaptein, Sofie Jacobs, Lana Langendries

|May 15, 2020
To pool or not to pool? Screening of Chlamydia trachomatis and Neisseria gonorrhoeae in female sex workers: pooled versus single-site testing.

Nick Verougstraete, Vanessa Verbeke, Anne-Sophie De Cannière

Pageof 2